Plant-Based Oil-in-Water Food Emulsions: Exploring the Influence of Different Formulations on Their Physicochemical Properties.

The global focus on incorporating natural ingredients into the diet for health improvement encompasses ω-3 polyunsaturated fatty acids (PUFAs) derived from plant sources, such as flaxseed oil. ω-3 PUFAs are susceptible to oxidation, but oil-in-water (O/W) emulsions can serve to protect PUFAs from this phenomenon. This study aimed to create O/W emulsions using flaxseed oil and either soy lecithin or Quillaja saponins, thickened with modified starch, while assessing their physical properties (oil droplet size, ζ-potential, and rheology) and physical stability. Emulsions with different oil concentrations (25% and 30% w/w) and oil-to-surfactant ratio (5:1 and 10:1) were fabricated using high-pressure homogenization (800 bar, five cycles). Moreover, emulsions were thickened with modified starch and their rheological properties were measured. The physical stability of all emulsions was assessed over a 7-day storage period using the TSI (Turbiscan Stability Index). Saponin-stabilized emulsions exhibited smaller droplet diameters (0.11-0.19 µm) compared to lecithin (0.40-1.30 µm), and an increase in surfactant concentration led to a reduction in droplet diameter. Both surfactants generated droplets with a high negative charge (-63 to -72 mV), but lecithin-stabilized emulsions showed greater negative charge, resulting in more intense electrostatic repulsion. Saponin-stabilized emulsions showed higher apparent viscosity (3.9-11.6 mPa·s) when compared to lecithin-stabilized ones (1.19-4.36 mPa·s). The addition of starch significantly increased the apparent viscosity of saponin-stabilized emulsions, rising from 11.6 mPa s to 2117 mPa s. Emulsions stabilized by saponin exhibited higher stability than those stabilized by lecithin. This study confirms that plant-based ingredients, particularly saponins and lecithin, effectively produce stable O/W emulsions with flaxseed oil, offering opportunities for creating natural ingredient-based food emulsions.

Cuantificación de metales en LECISAN®por espectrometría de emisión óptica con plasma acoplado inductivamente

Introducción: La contaminación resultante de la industrialización ha propiciado el aumento de la concentración de metales en diversos ambientes y su incorporación a materias primas y productos terminados, lo que repercute directamente en la salud humana. Objetivo: Cuantificar metales en la materia prima empleada en la fabricación de la tableta masticable LECISAN® y en la tableta, para establecer niveles de referencia de: aluminio, calcio, cadmio, cromo, cobre, hierro, magnesio, plomo, silicio, vanadio y zinc. Método: Se utilizó la espectrometría atómica de emisión óptica con plasma inductivamente acoplado (ICP OES) y se establecieron mediante métodos estadísticos los intervalos de confianza para la media de los valorescuantificados con una probabilidad del 95%. Resultados: Existen diferencias significativas entre las dos formas de presentación en cuanto a la cantidad de todos los metales, excepto aluminio (p<0,05). Los coeficientes de variación fueron bajos, el cromo obtuvo un valor cercano al 10% en la materia prima y el plomo resultó elevado (17,44 %). Los valores se encuentran dentro del rango reportado como permisibles según norma cubana (NC 493:2012) excepto para plomo y cobre. Se observaron mayores concentraciones de aquellos elementos con efectos favorables para la salud. Conclusiones: Los resultados encontrados deben ser considerados como referenciales para la evaluación del impacto que sobre la salud tendría el régimen de administración diaria del suplemento nutricionalLECISAN® yel análisis de factores relacionados con la presencia de metales en subproductos del refinado del aceite de soya para futura investigaciones.

Introduction: The pollution resulting from industrialization has led to an increase in the concentration of metals in various environments and their incorporation into raw materials and finished products, which has a direct impact on human health. Objective: To quantify metals in the raw material used in the manufacture of the LECISAN® chewable tablet and in the tablet, to establish reference levels of: aluminum, calcium, cadmium, chromium, copper, iron, magnesium, lead, silicon, vanadium and zinc. Method: Atomic optical emission spectrometry with inductively coupled plasma (ICP OES) was used and confidence intervals for the mean of the quantified values were established using statistical methods with a probability of 95%. Results: There are significant differences between the two presentation forms in terms of the amount of all metals, except aluminum (p<0.05). The variation coefficients were low, chromium obtained a value close to 10% in the raw material and lead was high (17.44%). The values are within the range reported as permissible according to Cuban standards (NC 493:2012) except for lead and copper. Higher concentrations of those elements with favorable health effects were observed. Conclusions: The results found should be considered as references for the evaluation of the impact that the daily administration regimen of the LECISAN® nutritional supplement would have on health and the analysis of factors related to the presence of metals in by-products of soybean oil refining for future research.

Introdução: A poluição decorrente da industrialização tem levado ao aumento da concentração de metais em diversos ambientes e à sua incorporação em matérias-primas e produtos acabados, o que tem impacto direto na saúde humana. Objetivo: Quantificar metais na matéria-prima utilizada na fabricação do comprimido mastigável LECISAN® e no comprimido, estabelecer teores de referência de: alumínio, cálcio, cádmio, cromo, cobre, ferro, magnésio, chumbo, silício, vanádio e zinco. Método: Foi utilizada espectrometria de emissão óptica atômica com plasma indutivamente acoplado (ICP OES) e os intervalos de confiança para a média dos valores quantificados foram estabelecidos por meio de métodos estatísticos com probabilidade de 95%. Resultados: Existem diferenças significativas entre as duas formas de apresentação quanto à quantidade de todos os metais, exceto alumínio (p<0,05). Os coeficientes de variação foram baixos, o cromo obteve valor próximo a 10% na matéria-prima e o chumbo foi alto (17,44%). Os valores estão dentro da faixa informada como permitida segundo as normas cubanas (NC 493:2012) exceto para chumbo e cobre. Foram observadas concentrações mais elevadas desses elementos com efeitos favoráveis à saúde. Conclusões: Os resultados encontrados devem ser considerados referências para a avaliação do impacto que o regime diário de administração do suplemento nutricional LECISAN® teria na saúde e a análise dos fatores relacionados à presença de metais em subprodutos do refino do óleo de soja para pesquisas futuras.

Efectos de la lecitina de soya en parámetros hematológicos y marcadores inflamatorios sistémicos de ratas / Effects of soy lecithin on hematological parameters and systemic inflammatory markers of rats

Introducción: El estudio de los efectos farmacológicos preclínicos de la lecitina de soya sobre parámetros hematológicos y marcadores inflamatorios sistémicos, contribuirá a sustentar las bases de su posible empleo como medicamento natural. Objetivo: Determinar los efectos de la lecitina de soya sobre parámetros hematológicos y marcadores inflamatorios sistémicos de ratas Wistar. Métodos: Se realizó un estudio de farmacología preclínica experimental, en el que se administró lecitina de soya en dosis máximas y mínimas a dos grupos experimentales de ratas Wistar. Se estimaron variables hematológicas para ser comparadas con el grupo control, se determinó recuento diferencial y el conteo global de leucocitos según fórmula avanzada como indicativo indirecto de inmunocompetencia. Se calcularon como marcadores inflamatorios sistémicos la relación neutrófilos-linfocitos (N/LR) y la relación plaquetas-linfocitos (P/LR). La existencia de diferencias de medianas y rangos de las diferentes variables entre los grupos se reveló mediante la Prueba de Kruskal-Wallis de muestras independientes con nivel de significancia de p <0.05. Resultados: Se observó leucopenia, aumento del recuento plaquetario y alteraciones de índices relacionados con la inflamación y la inmunidad en ambos grupos experimentales, relacionado con la dosis. La N/LR y P/LR se incrementaron de manera proporcional con la dosis y el índice de inmunidad e inflamación sistémica se incrementa con dosis mínima y tiende a decrecer con dosis máxima. Conclusiones: El producto modifica parámetros hematológicos en ratas, pero se requieren otros estudios controlados que corroboren el estado de inmunocompetencia, tomando en consideración lo que expresan los marcadores inflamatorios sistémicos.

Introduction: The study of the preclinical pharmacological effects of soy lecithin on hematological parameters and systemic inflammatory markers, will contribute to support the foundations of its possible use as a natural medication. Objective: To determine the effects of soy lecithin on hematological parameters and systemic inflammatory markers of Wistar rats. Methods: An experimental preclinical pharmacology study was conducted, in which soy lecithin was administered in maximum and minimum doses of two experimental Wistar rats. Hematological variables were estimated to be compared to the control group, differential counting and global leukocyte count according to advanced formula as an indirect indicative of immunocompetence was determined. The neutrophil-linfocyte (N/LR) and the platelet-linfocyte ratio (P/LR) were calculated as systemic inflammatory markers. The existence of medium and ranges differences of the different variables between the groups was revealed by the Kruskal-Wallis test of independent samples with a level of significance of p<0.05. Results: Leukopenia, increased platelet count and alterations of inflammation related to inflammation and immunity dose-related were observed in both experimental groups. The N/LR and P/LR were proportionally increased with the dose and the system of systemic immunity and inflammation is increased with minimal dose and tends to decrease with maximum dose. Conclusions: The product modifies hematological parameters in rats, but other controlled studies are required that corroborate the state of immunocompetence, taking into consideration what systemic inflammatory markers express.

Electrospinning Microencapsulation of Lactobacillus fermentum K73 Using Gelatin as the Main Component of a Food-Grade Matrix.

This work aimed to establish the conditions that improve the viability of Lactobacillus fermentum K73 during and after the electrospinning process. A mixture of experimental designs were performed to select the formulation (gelatin and bacterial culture) that improves the probiotic viability after blending and under simulated gastrointestinal conditions. A Box-Behnken design was performed to improve the encapsulation yield and survival during the electrospinning process. For the Box-Behnken design, the factors were soy lecithin and bacteria culture concentration at the blend and collector distance for electrospinning. It was hypothesized that soy lecithin improved the electrospinnability, acting as a surfactant in the mixture and allowing lower voltage to be used during the process. The selected volume ratio of the gelatin (25%)/bacterial culture mixture was 0.66/0.34. The physicochemical parameters of the selected blend were in the recommended range for electrospinning. The conditions that improved the encapsulation yield and survival during electrospinning were 200 g/L of bacterial culture, 2.5% (w/v) soy lecithin, and 7 cm collector distance. The experimental encapsulation yield and survival was 80.7%, with an experimental error of 7.2%. SEM micrographs showed the formation of fibers with gelatin/bacterial culture beads. Encapsulation improved the viability of the probiotic under simulated gastrointestinal conditions compared to free cells.

Preclinical evaluation of the effects of soy lecithin on body composition / Evaluación preclínica de los efectos de la lecitina de soya sobre la composición corporal

Introduction: Soy lecithin has become one of the most widely used dietary supplements with potential to treat obesity. Objective: To determine the effect of soy lecithin on body composition. Material and Methods: An experimental preclinical pharmacology study was carried out in the Laboratory of Antibodies and Experimental Biomodels (Labex-cim) and the Basic Sciences Laboratory of the University of Medical Sciences of Santiago de Cuba in 2019. Soy lecithin was administered for 30 days, in doses considered as maximum and minimum to two experimental groups of Wistar rats, to be compared with the control group that received regular feeding. Bioelectric variables and indicators of fat mass were estimated by establishing differences between the experimental groups using the Kruskal-Wallis test of independent samples and considering the level of significance less than 5 %. Results: Total body water, fat-free mass, extracellular water, and total body fat changed significantly compared to the control and between groups; also, there were variations in fat weight in the main compartments, increasing in the group supplemented at the minimum dose and reducing in the group that received the maximum dose of the product. The phase angle showed reduction in both experimental groups. Conclusions: Soy lecithin, depending on the dose, modifies the body composition in rats, the phase angle being an appreciable parameter for nutritional evaluation.

Introducción: La lecitina de soya se ha convertido en un suplemento dietético de los más utilizados con potencialidades para tratar la obesidad. Objetivo: Determinar el efecto de la lecitina de soya sobre la composición corporal. Material y Métodos: Se realizó un estudio de farmacología preclínica experimental en el Laboratorio de Anticuerpos y Biomodelos Experimentales (Labex-cim) y el Laboratorio de Ciencias Básicas de la Universidad de Ciencias Médicas de Santiago de Cuba, en 2019. Se administró lecitina de soja por 30 días, en dosis consideradas como máximas y mínimas a dos grupos experimentales de ratas Wistar, para ser comparados con grupo control que recibió alimentación habitual. Se estimaron variables bioeléctricas e indicadores de masa grasa estableciendo diferencias entre los grupos experimentales mediante la Prueba de Kruskal-Wallis de muestras independientes y considerando el nivel de significación menor del 5 %. Resultados: El agua corporal total, la masa libre de grasa, el agua extracelular y la grasa corporal total se modificaron de manera significativa en comparación con el control y entre grupos, así como existieron variaciones en el peso de la grasa en los compartimentos principales, incrementándose en el grupo suplementado a dosis mínima y reduciendo en el grupo que recibió dosis máxima del producto. El ángulo de fase mostró reducción en ambos grupos experimentales. Conclusiones: La lecitina de soya, dependiendo de la dosis, modifica la composición corporal en ratas siendo el ángulo de fase un parámetro apreciable para la evaluación nutricional.

Effect of emulsifier addition on metabolizable energy reduction in broiler diets / Adição de emulsificante nas rações de frangos de corte com redução dos níveis de energia metabolizável

This study aimed to evaluate the effect of including soy lecithin emulsifier (SL) in broiler diets with reduced metabolizable energy levels and to correlate it with nutrient metabolizability coefficients, as well as to determine apparent metabolizable energy (AME). Two metabolic trials were conducted in a completely randomized design with a 3x2 factorial arrangement (diet with three levels of metabolizable energy, with or without the inclusion of emulsifier), totaling six treatments. In the starter phase, chicks received diets with 2,950, 3,050, and 3,150 kcal/kg of metabolizable energy, with six replications of 10 birds each, totaling 360 birds. In the grower phase, the energy levels of 3,100, 3,150, and 3,200 kcal/kg of feed were tested in 210 birds were used in seven replications of five chicks each. An interaction effect was observed in the starter phase, with the nitrogen metabolizability coefficient increasing when the emulsifier was added to diets with reduced energy. Additionally, emulsifier inclusion increased nitrogen-corrected AME (AMEn). An interaction effect was also present in the grower phase, with AME and AMEn increasing when the emulsifier was added to diets with lower energy levels. In summary, emulsifier inclusion in broiler diets can reduce metabolizable energy while improving AMEn in both the starter and grower phases, as well as AME in growing broilers.

Objetivou-se avaliar a adição do emulsificante, lecitina de soja, nas rações de frangos com redução dos níveis de energia metabolizável e correlacioná-las com os coeficientes de metabolizabilidade de nutrientes, além da determinação da energia metabolizável aparente (EMA). Realizou-se dois ensaios metabólicos em delineamento inteiramente casualizados, esquema fatorial 3x2 (ração com três níveis de energia metabolizável, com ou sem a inclusão do emulsificante na dieta), totalizando seis tratamentos. Na fase inicial, os pintos receberam dieta com 2.950, 3.050 e 3.150 kcal/kg de energia metabolizável, com seis repetições com 10 aves, totalizando 360 aves. Na fase de crescimento foram utilizadas 210 aves, sendo sete repetições com cinco frangos e os níveis de energia testados foram: 3.100, 3.150 e 3.200 kcal/kg de ração. Na fase inicial, observou-se efeito de interação, apresentando aumento do coeficiente de metabolizabilidade do nitrogênio (CMN) ao adicionar o emulsificante em dietas com energia reduzida e também, efeito do emulsificante no aumento da energia metabolizável aparente corrigida pelo balanço do nitrogênio (EMAn). Na fase de crescimento, observou-se efeito de interação, apresentando aumento da EMA e EMAn ao adicionar o emulsificante em dietas com menores níveis de energia. Conclui-se que a inclusão do emulsificante é indicada para frangos de corte, pois permite reduzir a energia metabolizável da dieta, melhorando a EMAn nas fases inicial e de crescimento, bem como a da EMA com frangos em crescimento.

Effect of exogenous emulsifier and different fat sources on the performance, carcass characteristics, nutrient digestibility, and serum lipid profile of broiler chickens / Efeito de emulsificante exógeno e diferentes fontes de gordura no desempenho, características de carcaça e digestibilidade de nutriente e perfil lipídico sérico em frangos de corte

A study was conducted to evaluate the effect of an emulsifier on reduced-energy diets using two fat sources for broilers. The study was designed as a 2 x 3 factorial arrangement of treatments. The first factor was 2 fat sources (poultry fat or beef tallow). The second factor was a basal diet with the recommended energy levels, a diet with a 0.83 MJ/kg of energy reduction, and a diet with an energy reduction and inclusion of 1 g emulsifier/kg of diet. The emulsifier used in this study was composed of soy lecithin and polyethylene glycol ricinoleate. The emulsifier increased apparent metabolizable energy (AME) and apparent metabolizable energy corrected for nitrogen balance (AMEn) in beef tallow diets compared to energy-reduced diets (P<0.001). Broilers fed poultry fat had higher weights and weight gains at 35 and 42 d of age (p=0.001), and they had higher daily deposition of fat in the carcass (P = 0.025) when compared to diets with beef tallow. The inclusion of emulsifiers in broiler diets improves AME and AMEn but did not affect the energy reduction diets, which resulted in reduced performance, decreasing daily fat deposition, but without effects on serum lipid profile in broilers.(AU)

Um estudo foi conduzido para avaliar o efeito de um emulsificante em dietas com baixo teor de energia usando duas fontes de gordura para frangos de corte. O estudo foi delineado em arranjo fatorial 2 x 3 de tratamentos, o primeiro fator foi 2 fontes de gordura (gordura de frango ou sebo bovino) e o segundo fator uma dieta basal com os níveis de energia recomendados, uma dieta com 0,83 MJ / kg de redução de energia e uma dieta com redução de energia e inclusão de 1 g de emulsionante / kg de dieta (composto de lecitina de soja e ricinoleato de polietilenoglicol). O emulsificante aumentou a energia metabolizável aparente (EMA) e a energia metabolizável aparente corrigida para o balanço de nitrogênio (EMAn) em dietas com sebo bovino em comparação com dietas com redução de energia (P <0,001). Frangos de corte alimentados com gordura de frango apresentam maiores pesos e ganhos de peso aos 35 e 42 dias de idade (p=0,001), e maior deposição diária de gordura na carcaça (P=0,025) quando comparados às dietas com sebo bovino. O emulsificante incluído nas dietas de frangos de corte melhora a EMA e EMAn, mas não supre a redução energética, causando efeitos negativos no desempenho, diminuindo a deposição diária de gordura, mas sem efeitos no perfil lipídico sérico em frangos de corte.(AU)

LECISAN® y sus potencialidades terapéuticas para el abordaje farmacológico de la obesidad / LECISAN® and its therapeutic potentialities for the pharmacological approach to obesity

Introducción: La obesidad se ha identificado como un estado crónico de inflamación sistémica conocido como lipoinflamación. En los últimos tiempos ha cobrado relevancia el descubrimiento de moléculas clave que actúan como blancos terapéuticos, así como sus conexiones y mecanismos existentes. Por otra parte, es sabido lo difícil que es la obtención de nuevos fármacos naturales como alternativas o terapias complementarias en enfermedades crónicas no transmisibles como la obesidad y las dislipemias. El LECISAN® destaca como candidato por sus potencialidades. Objetivos: Valorar los resultados de investigaciones preclínicas y clínicas que avalan el uso del LECISAN®. Métodos: Se realizó una revisión sistemática y crítica de las evidencias de impacto de los efectos de la lecitina de soya. Se consultaron artículos publicados preferentemente en los últimos diez años en las bases de datos EBSCO, Google Scholar, Latindex, Redalyc, DOAJ, Dialnet, WorldCat, LILACS, SciELO y OATD. Conclusiones: El LECISAN® es un producto natural que rebasa el contexto de su empleo como suplemento nutricional, pero requiere nuevas investigaciones en el campo de la farmacología. Resultan contradictorios y poco concluyentes los resultados referentes a sus posibles efectos y usos(AU)

Introduction: Obesity has been identified as a chronic state of systemic inflammation known as lipoinflammation. In recent times, the discovery of key molecules acting as therapeutic targets, as well as their connections and existing mechanisms, has gained relevance. On the other hand, it is known how difficult it is to obtain new natural drugs as alternatives or complementary therapies in chronic noncommunicable diseases such as obesity and dyslipidemias. LECISAN® stands out as a candidate, for its potentialities. Objective: To assess the results of preclinical and clinical investigations that support the use of LECISAN®. Methods: A systematic and critical review of evidence about the impact of the effects of soy lecithin was carried out. Articles published preferably in the last ten years were consulted, from the EBSCO, Google Scholar, Latindex, Redalyc, DOAJ, Dialnet, WorldCat, LILACS, SciELO and OATD databases. Conclusions: LECISAN® is a natural product that goes beyond the context of its use as a nutritional supplement, but requires new research in the field of pharmacology. The results regarding its possible effects and uses are contradictory and inconclusive, based on hypotheses that relate an emulsifying action with the phospholipids present in the mixture, the antioxidant effects with isoflavones, the anti-inflammatory effects with the polyunsaturated fatty acids that regulate lipid metabolism, as well as the activation of the phospholipase A2 system with the consequent production of inflammatory cytosines(AU)

Effects of Soy Lecithin Extender on Dog Sperm Cryopreservation.

Semen cryopreservation is an essential biotechnology in canine reproduction and during the cryopreservation process commonly egg yolk are used. The discrepancy in the egg yolk composition and the potential risk of disease dissemination are obstacles for semen exportation and use. Therefore, studies aiming to substitute egg yolk are extremely important. In this context, soy lecithin contains a low-density lipoprotein fraction, is an interesting alternative. Thus, the objective of this study was to compare extenders based on soy lecithin (several concentrations and forms) with egg yolk during the cryopreservation process of dog sperm. For this purpose, we used twelve dogs. Semen was evaluated at different time points (after refrigeration, glycerolization, and thawing), by motility analysis (CASA) and functional tests (e.g., membrane integrity-eosin/nigrosin, acrosome integrity-fast green/Bengal rose, mitochondrial activity-3'3 diaminobenzidine, Chromatin susceptibility to acid-induced denaturation-SCSA, and susceptibility to oxidative stress-thiobarbituric acid reactive substances). The results indicated that egg yolk and lower concentrations of lecithin had similar effects on mitochondrial activity and motility. Thus, soy lecithin is a potentially viable alternative to egg yolk for the cryopreservation of dog semen.

Beef tallow and emulsifier in growing-finishing pig diets

ABSTRACT Two trials were aimed to evaluate beef tallow in diets with and without emulsifier on performance of pigs at growing-finishing phases. In the first trial, 15 barrows (22.03±0.62 kg) were distributed among three treatments: reference diet; test diet 1 (5% beef tallow) and test diet 2 (10% beef tallow). Beef tallow presented average value of 7130.97 kcal ME/kg. For the performance trail, 30 barrows (24.85±1.18 kg) were distributed among five treatments: T1 - diet with soybean oil and 3230 kcal ME /kg; T2 - diet with beef tallow and 3230 kcal ME/kg; T3 - diet with beef tallow and 3080 kcal ME/kg; T4 - diet with beef tallow, 3080 kcal/kg and 0.1% emulsifier; T5 - diet with beef tallow, 2930 kcal ME/kg and 0.1% emulsifier. Feed conversion was worse in animals fed diet with 3080 kcal ME/kg containing beef tallow and with 2930 kcal ME/kg with beef tallow and emulsifier. For economic availability, animals fed diet with beef tallow and 3230 kcal ME/kg and those fed diet with 3080 kcal ME/kg containing beef tallow and emulsifier, did not differ from animals fed diet with soybean oil, which enables the reduction up to 150 kcal ME/kg be compensated by emulsifier addition.

Efeito da utilização de diferentes diluidores para a produção in vitro de embriões bovinos / Effect of different bovine semen extenders on in vitro development of bovine embryos

Objetivou-se avaliar as características morfológica e funcional do sêmen bovino congelado comparando-se a eficácia de dois diferentes diluidores. O ejaculado de quatro touros foi dividido em duas partes iguais, uma submetida ao diluidor Tris e gema de ovo (A) e outra ao diluidor à base de lecitina de soja (Andromed®) (B). No experimento I, cinco palhetas dos diluidores A e B de cada touro foram descongeladas e avaliadas quanto à motilidade, vigor, concentração, morfologia espermática e teste de termor-resistência lento. Foram feitas, ainda, avaliação da integridade de membranas, por meio da associação das sondas iodeto de propídio, isotiocionato de fluoresceína - Pisum sativum e carbocianina catiônica lipofílica, e avaliação funcional da membrana plasmática com teste hiposmótico. A avaliação da integridade da cromatina foi realizada pelo método de coloração com laranja de acridina. No experimento II, o sêmen com os diferentes diluidores foi utilizado na fecundação in vitro, sendo observadas taxas de clivagem e desenvolvimento embrionário in vitro. Em relação aos resultados obtidos, apenas a porcentagem de espermatozoides no sêmen congelado foi discretamente maior com o diluidor A, concluindo-se que o diluidor composto por lecitina de soja pode substituir o composto por Tris e gema de ovo, respeitando-se as variações individuais de cada touro utilizado no presente experimento.

The goal of this study was to evaluate the protective effect of egg yolk compared with a soybean lecithin-based extender on morphologic and functional characteristics of frozen bovine semen. The ejaculate of four bulls was divided into two equal parts, one diluted with egg-yolk-Tris extender (A) and the other with a soy-lecithin based extender (Andromed®) (B). In experiment I, five straws of extender A and B from each bull were thawed and assessed regarding motility (subjective and computerized analysis), vigor, concentration, sperm morphology and slow thermoresistance (STR), evaluation of membrane integrity through association of propidium iodite probes (PI), fluorescein isotiocianate - Pisum sativum (FITC-PSA) and lipophilic cationic carbocyanine (JC-1) and functional evaluation of the plasmatic membrane through Hyposmotic Swelling Test (HOST). An evaluation of chromatin integrity was performed with the acridine orange staining procedure. In experiment II, the frozen semen with different extenders was used for in vitro fertilization (IVF), analyzing cleavage rates and in vitro embryo development. No statistical difference between extenders was identified, suggesting that the soy lecithin extender may substitute egg-yolk-Tris extender, considering the individual variations of each bull used in this experiment.

Utilização da lecitina de soja para a refrigeração e criopreservação do sêmen de cães / Effect of soy lecithin on dog semen refrigeration and cryopreservation

Sabe-se que a criopreservação do sêmen provoca uma perda significativa na qualidade espermática. Apesar de diversos estudos visando à melhora na qualidade do sêmen pós-descongelamento, é de consenso geral que a gema de ovo apresenta uma significante capacidade em evitar as crio-injúrias. No entanto, a grande variação na sua composição, assim como o risco potencial para a contaminação do diluidor, caso certos contaminantes estejam no produto in natura, são empecilhos para sua utilização para a exportação do sêmen, assim como sua utilização em humanos. Deste modo, estudos visando substituir a gema de ovo por produtos quimicamente definidos e de origem não-animal, são de extrema importância. Neste contexto, a lecitina da soja, por possuir uma fração de lipoproteína de baixa densidade semelhante à encontrada na gema de ovo, pode ser uma alternativa interessante. O presente estudo visa comparar diluidores a base de lecitina de soja e aqueles contendo gema de ovo utilizados rotineiramente para a refrigeração e criopreservação do sêmen canino. Para isto, foi utilizado o sêmen de 12 cães adultos, que foi refrigerado e criopreservado em diluidores a base de gema de ovo (OVO) e a base de lecitina de soja (LEC) em diferentes concentrações (0,01; 0,05 e 0,1%) e apresentações (FP40, 8160 e Solec F). O sêmen foi avaliado após refrigeração (2, 24, 48, 72, 96 e 120 horas; Experimento 1) e após criopreservação (pós refrigeração, pós glicerolização e pós descongelação; Experimento 2) através da análise convencional do sêmen (i.e., motilidade - CASA) e funcionais (i.e., integridade de membrana - eosina/nigrosina; integridade de acrossomo - Fast Green / Rosa Bengala; atividade mitocondrial - 3´3 Diaminobenzidina; fragmentação do DNA - SCSA; susceptibilidade ao estresse oxidativo - substâncias reativas ao ácido tiobarbitúrico). Os resultados do Experimento 1 indicaram que, semelhante ao ovo, todas as lecitinas na concentração 0,01% foram capazes de manter a motilidade em torno de 50% por até 72 horas. Após 96 horas, o diluidor Solec F apresentou melhor resultado em relação ao ovo na atividade mitocondrial, e após 120 horas a concentração 0,01%, apresentou maior motilidade do que o ovo (30,00 ± 10,69; 8,33 ± 1,84, respectivamente). No sêmen criopreservado (Experimento 2), as menores concentrações de lecitina apresentaram resultados semelhantes ao ovo tanto na motilidade quanto na atividade mitocondrial. Os resultados indicam que a lecitina pode ser uma boa alternativa à gema de ovo para a refrigeração e criopreservação do sêmen canino

Semen cryopreservation, an essential step on biotechnologies applied to reproduction, is known to induce significant loss on sperm quality. Despite several studies aiming to improve post-thaw quality, it is generally agreed that egg yolk is the most effective in protecting sperm against cryo-injuries. However, the considerable variation on egg yolk composition as well as the potential risk of disseminating diseases when used in natura, are obstacles to semen exportation as well as the use in human. Therefore, studies aiming to substitute the egg yolk for chemically defined components or animal free products are extremely important. In this context, soy lecithin, which contains a fraction of low density lipoprotein, appears to be an interesting alternative. Thus, the present study aims to compare semen extenders containing soy lecithin or egg yolk on dog semen cryopreservation and refrigeration. Towards this aim, semen of 12 adult dogs were be refrigerated and cryopreserved in Tris-Fructose-Citric acid extenders with egg yolk (OVO) or soy lecithin (LEC; in different concentrations - 0,01; 0,05; 0,1% and presentations - FP40; 8160; Solec F). Semen was evaluated after chilling (2, 24, 48, 72, 96 and 120 hours; Experiment 1) and after cryopreservation (post refrigeration, post-glycerolization, and post-thaw; Experiment 2) for routine semen analysis (e.g., motility, CASA) and functional tests (e.g., membrane integrity - eosin/nigrosin; acrosome integrity - fast green/Bengal rose; mitochondrial activity - 3´3 diaminobenzidine; DNA fragmentation - SCSA; susceptibility to oxidative stress - thiobarbituric acid reactive substances). Results were statistically analyzed using the SAS System for Windows. Results of experiment 1 indicate that, similar to the egg yolk, all types of lecithin used in the 0.01% concentration, were able to maintain sperm motility around 50% for 72 h. After 96 h, the extender containing the lecithin Solec F showed better results regarding mitochondrial activity when compared to the egg yolk. Furthermore, after 120 h, the same extender with the 0.01% concentration, showed higher motility when compared to the egg yolk (30.00 ± 10.69 and 8.33 ± 1.84%, respectively). On the other hand, for the cryopreserved samples (Experiment 2), lower concentrations of lecithin showed similar results for mitochondrial activity and motility when compared to the egg yolk. Results found in the present study indicate that soy lecithin may be a good alternative to substitute the egg yolk for both refrigeration and cryopreservation of dog semen

Efeito da utilização de diferentes diluidores para a produção in vitro de embriões bovinos / Effect of different bovine semen extenders on in vitro development of bovine embryos

Objetivou-se avaliar as características morfológica e funcional do sêmen bovino congelado comparando-se a eficácia de dois diferentes diluidores. O ejaculado de quatro touros foi dividido em duas partes iguais, uma submetida ao diluidor Tris e gema de ovo (A) e outra ao diluidor à base de lecitina de soja (Andromed®) (B). No experimento I, cinco palhetas dos diluidores A e B de cada touro foram descongeladas e avaliadas quanto à motilidade, vigor, concentração, morfologia espermática e teste de termor-resistência lento. Foram feitas, ainda, avaliação da integridade de membranas, por meio da associação das sondas iodeto de propídio, isotiocionato de fluoresceína - Pisum sativum e carbocianina catiônica lipofílica, e avaliação funcional da membrana plasmática com teste hiposmótico. A avaliação da integridade da cromatina foi realizada pelo método de coloração com laranja de acridina. No experimento II, o sêmen com os diferentes diluidores foi utilizado na fecundação in vitro, sendo observadas taxas de clivagem e desenvolvimento embrionário in vitro. Em relação aos resultados obtidos, apenas a porcentagem de espermatozoides no sêmen congelado foi discretamente maior com o diluidor A, concluindo-se que o diluidor composto por lecitina de soja pode substituir o composto por Tris e gema de ovo, respeitando-se as variações individuais de cada touro utilizado no presente experimento.(AU)

The goal of this study was to evaluate the protective effect of egg yolk compared with a soybean lecithin-based extender on morphologic and functional characteristics of frozen bovine semen. The ejaculate of four bulls was divided into two equal parts, one diluted with egg-yolk-Tris extender (A) and the other with a soy-lecithin based extender (Andromed®) (B). In experiment I, five straws of extender A and B from each bull were thawed and assessed regarding motility (subjective and computerized analysis), vigor, concentration, sperm morphology and slow thermoresistance (STR), evaluation of membrane integrity through association of propidium iodite probes (PI), fluorescein isotiocianate - Pisum sativum (FITC-PSA) and lipophilic cationic carbocyanine (JC-1) and functional evaluation of the plasmatic membrane through Hyposmotic Swelling Test (HOST). An evaluation of chromatin integrity was performed with the acridine orange staining procedure. In experiment II, the frozen semen with different extenders was used for in vitro fertilization (IVF), analyzing cleavage rates and in vitro embryo development. No statistical difference between extenders was identified, suggesting that the soy lecithin extender may substitute egg-yolk-Tris extender, considering the individual variations of each bull used in this experiment.(AU)

Efeito da Lecitina de Soja sobre os Lipídeos e Proteína C reativa e na prevenção da Hipertrofia Ventricular Esquerda de Camundongos Hiperlipidêmicos / Effect of soy lecithin on lipids and C-reactive protein and the prevention of Left Ventricular Hypertrophy in hyperlipidemic mice

A regulação do metabolismo lipídico com drogas ou alimentos naturais é um alvo importante para diminuir o risco de doenças cardiovasculares. O objetivo deste estudo foi verificar o efeito da lecitina de soja na dislipidemia e na hipertrofia ventricular de camundongos hipercolesterolêmicos. Utilizaram-se quatro grupos de camundongos LDLr-/- com 3 meses de idade que receberam a seguintes dietas: Grupo S- ração padrão; Grupo S+Lec- ração padrão e lecitina de soja; Grupo HL- ração hiperlipídica; e Grupo HL+Lec- ração hiperlipídica e lecitina de soja. Após 15 dias, o sangue foi coletado para análise sérica dos lipídeos e da proteína C reativa. O ventrículo esquerdo foi separado, a proporção peso ventricular (mg) pelo peso do animal (g) foi calculada e, em seguida, processado histologicamente. Cortes histológicos foram corados com hematoxilina/eosina e picrosírius red para avaliar alterações morfológicas e morfométricas ventriculares. A lecitina de soja apresentou efeito antidislipidêmico e aumentou os níveis séricos de HDL nos camundongos do grupo S+Lec. Entretanto, nos camundongos do grupo HL+lec, a lecitina de soja não preveniu a dislipidemia, apenas aumentou o nível sérico do HDL. Este efeito nestes animais influenciou no processo inflamatório cardiovascular, reduzindo o nível sérico de proteína C reativa; e prevenindo a hipertrofia ventricular esquerda. A utilização da lecitina de soja representa um tratamento e/ou uma prevenção alternativa de baixo custo para as dislipidemias não associadas com dieta hiperlipídica. Contudo, a lecitina de soja aumenta os níveis séricos do HDL prevenindo o desenvolvimento da HVE mesmo em dislipidemias associadas com dieta hiperlipídica.

The regulation of lipid metabolism with drugs or natural foods is an important target for reducing the risk of cardiovascular disease. The aim of this study was to investigate the effects of soy lecithin on left ventricular hypertrophy (LVH) and dyslipidemia in hypercholesterolemic mice. We used four experimental groups of LDLr-/- mice (aged 3 months), which received the following diets: Group S: standard diet, Group S+Lec: standard diet and soy lecithin; Group HL: hyperlipidic diet and Group HL+Lec: hyperlipidic diet and soy lecithin. After 15 days on these diets, blood was collected for analysis of serum lipids and C-reactive protein. The left ventricle was dissected out and weighed and the ratio of its weight to the body weight of the animal was calculated, after which it was processed histologically. Sections were stained with hematoxylin-eosin and picrosirius red, to assess morphological and morphometric changes in the ventricle. In Group S+Lec, the soy lecithin had an antidyslipidemic effect and enhanced the serum levels of HDL. However, in the mice in group HL+Lec, soy lecithin did not prevent dyslipidemia, only increasing the serum level of HDL. These effects in these animals influenced the cardiovascular inflammatory process, reducing the level of serum C-reactive protein and preventing LVH. Soy lecithin could thus be used as a treatment or a low-cost alternative preventative measure against dyslipidemia associated with a non-fat diet. However, soy lecithin increases the serum level of HDL, reducing the risk of LVH even in dyslipidemia associated with a high-fat diet.